Evidence map›Paper›PMID 39350254›Full record

ArticleBMC medical informatics and decision making2024

Continuous adaptation of conversation aids for uterine fibroids treatment options in a four-year multi-center implementation project.

Danielle Schubbe, Marie-Anne Durand, Rachel C Forcino, Jaclyn Engel, Marisa Tomaino, Monica Adams-Foster, Carla Bacon, Carrie Cahill Mulligan, Sateria Venable, Tina Foster and 16 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical informatics and decision making, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Danielle SchubbeThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Marie-Anne DurandThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Rachel C ForcinoDepartment of Population Health, University of Kansas School of Medicine, Kansas City, KS, USA.
Jaclyn EngelThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Marisa TomainoRutgers Institute for Nicotine & Tobacco Studies, New Brunswick, NJ, USA.
Monica Adams-FosterThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Carla BaconNational Uterine Fibroids Foundation, Colorado Springs, CO, 80909, USA.
Carrie Cahill MulliganThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Sateria VenableFibroid Foundation, 10319 Westlake Dr, Suite 102, Bethesda, MD, 20817, USA.
Tina FosterThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Paul J BarrThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Raymond M AnchanDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Shannon Laughlin-TommasoDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Anne LindholmDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Maya SeshanDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rossella M GargiuloDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Patricia StephensonThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Karen GeorgeDepartment of Obstetrics and Gynecology, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
Mobolaji AjaoDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tessa MaddenDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO, USA.
Erika BanksDepartment of Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
Antonio R GargiuloDepartment of Obstetrics, Gynecology & Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
James O'MalleyThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA.
Maria van den MuijsenberghDepartment of Primary and Community Care, Radboud University Medical Centre, Nijmegen, The Netherlands.
Johanna W M AartsDepartment of Obstetrics and Gynaecology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Glyn ElwynThe Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, One Medical Center Drive, Williamson Translational Research Building Level 5, Lebanon, NH, 03756, USA. glynelwyn@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibroids are non-cancerous uterine growths that can cause symptoms impacting quality of life. The breadth of treatment options allows for patient-centered preference. While conversation aids are known to facilitate shared decision making, the implementation of these aids for uterine fibroids treatments is limited. We aimed to develop two end-user-acceptable uterine fibroids conversation aids for an implementation project. Our second aim was to outline the adaptations that were made to the conversation aids as implementation occurred.

methodsWe used a multi-phase user-centered participatory approach to develop a text-based and picture-enhanced conversation aid for uterine fibroids. We conducted a focus group with project stakeholders and user-testing interviews with eligible individuals with symptomatic uterine fibroids. We analyzed the results of the user-testing interviews using Morville's Honeycomb framework. Spanish translations of the conversation aids occurred in parallel with the English iterations. We documented the continuous adaptations of the conversation aids that occurred during the project using an expanded framework for reporting adaptations and modifications to evidence-based interventions (FRAME).

resultsThe first iteration of the conversation aids was developed in December 2018. Focus group participants (n = 6) appreciated the brevity of the tools and suggested changes to the bar graphs and illustrations used in the picture-enhanced version. User-testing with interview participants (n = 9) found that both conversation aids were satisfactory, with minor changes suggested. However, during implementation, significant changes were suggested by patients, other stakeholders, and participating clinicians when they reviewed the content. The most significant changes required the addition or deletion of information about treatment options as newer research was published or as novel interventions were introduced into clinical practice.

conclusionsThis multi-year project revealed the necessity of continuously adapting the uterine fibroids conversation aids so they remain acceptable in an implementation and sustainability context. Therefore, it is important to seek regular user feedback and plan for the need to undertake updates and revisions to conversation aids if they are going to be acceptable for clinical use.

Indexed as

LeiomyomaAdultDecision Making, SharedFemaleFocus GroupsHumansMiddle AgedUterine NeoplasmsImplementationShared decision makingUser-centered designUterine fibroids

Identifiers

PMID39350254
PMCPMC11441251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.